Clinical Trial Update: Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating methotrexate with LDL-like nanoparticles (Nano-COVID19) for patients with mild COVID-19 and associated inflammation; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease
• Inflammation

Drugs mentioned

• LDL-like nanoparticles
• METHOTREXATE (METHOTREXATE)
• Nano-COVID19 (methotrexate associated to LDL-like nanoparticles)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Coronavirus, Inflammation | Phase 1, Phase 2 | Status: UNKNOWN